An early-phase clinical trial of an experimental vaccine that targets cancer stem cells in patients with recurrent glioblastoma multiforme, the most common and aggressive malignant brain tumor, has been launched.
http://ift.tt/1cgr6Kz
http://ift.tt/1cgr6Kz
No comments:
Post a Comment